CYD19
CYD19 is a potent Snail/HDAC dual target inhibitor. CYD19 displays potent inhibitory activity against HDAC1 with an IC50 of 0.405 μM and potent inhibition against Snail with a Kd of 0.18 μM. CYD19 increases histone H4 acetylation in HCT-116 cells and decreases the expression of Snail protein to induce cell apoptosis[1].
Product Specifications
CAS Number
2415281-52-4
Product Name Alternative
Snail/HDAC-IN-1
UNSPSC
12352005
Target
HDAC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cyd19.html
Concentration
10mM
Purity
99.76
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(NC1=CC=C(F)C=C1N)C2=CC=C(CSC(N=C3NC4=NNC(C)=C4)=NN5C3=CC=C5)C=C2
Molecular Formula
C24H21FN8OS
Molecular Weight
488.54
References & Citations
[1]Cui H, et al. Design and synthesis of dual inhibitors targeting snail and histone deacetylase for the treatment of solid tumour cancer. Eur J Med Chem. 2022;229:114082.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HDAC1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ANT-13242-50ug 50 µg
Monkeypox virus / MPXV A44R Polyclonal Antibody
Sign In for Pricing
View Details 
151180 100 µg
APOBEC4 (Putative C->U-editing Enzyme APOBEC-4, Apolipoprotein B mRNA-editing Enzyme Catalytic Polypeptide-like 4, C1orf169, FLJ25691, MGC26594, RP1-127C7.4) discontinued
Sign In for Pricing
View Details